BUZZ-Amerant Bancorp's Q4 credit update disappointing but benign, Stephens says
I'm PortAI, I can summarize articles.
Wall Street brokerage Stephens describes Amerant Bancorp's Q4 credit update as disappointing but benign compared to previous updates. The regional lender reported $112.6 million in loans downgraded to non-accrual status, which was somewhat offset by paydowns and charge-offs. Persistent credit quality issues have raised concerns among investors, leading to the stock trading below tangible book value. Three out of four brokerages rate the stock as "buy" or higher, with a median price target of $21.50. As of the last close, AMTB stock is down 11.7% year-to-date.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments